IMCR (Immunocore Holdings plc American Depositary Shares)
Insider Trading Activity
Every open-market purchase and sale reported by IMCR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-28 | Siddharth Kaul | Director | A | — | — |
| 2026-05-28 | William Pao | Director | A | — | — |
| 2026-05-28 | John Irving Bell | Director | A | — | — |
| 2026-05-28 | Peter John Ratcliffe | Director | A | — | — |
| 2026-05-28 | Roy Steven Herbst | Director | A | — | — |
| 2026-05-28 | Kristine Peterson | Director | A | — | — |
| 2026-02-19 | Travis Alan Coy | Chief Financial Officer | A | — | — |
| 2026-02-19 | Bahija Jallal | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2026-02-19 | JOHN GOLL | SVP, FINANCE & CAO | MIXED | — | — |
| 2026-02-19 | Tina Amber St Leger | CHIEF HR OFFICER | MIXED | — | — |
| 2026-02-19 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-12-08 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-12-01 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-11-26 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-10-02 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-09-16 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-09-12 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2025-05-19 | William Pao | Director | A | — | — |
| 2025-05-19 | Kristine Peterson | Director | A | — | — |
| 2025-05-19 | Siddharth Kaul | Director | A | — | — |
| 2025-05-19 | Peter John Ratcliffe | Director | A | — | — |
| 2025-05-19 | John Irving Bell | Director | A | — | — |
| 2025-05-19 | Roy Steven Herbst | Director | A | — | — |
| 2025-05-19 | 667, L.P. | Director | A | — | — |
| 2025-03-19 | BAKER BROS. ADVISORS LP | Director | Buy | — | — |
| 2025-02-27 | William Pao | Director | A | — | — |
| 2025-02-19 | Bahija Jallal | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2025-02-19 | David M Berman | HEAD OF R&D | A | — | — |
| 2025-02-19 | Tina Amber St Leger | CHIEF HR OFFICER | A | — | — |
| 2025-02-19 | JOHN GOLL | SVP, FINANCE & CAO | A | — | — |
| 2025-01-03 | Travis Alan Coy | Chief Financial Officer | A | — | — |
| 2024-05-29 | BAKER BROS. ADVISORS LP | Director | A | — | — |
| 2024-05-28 | Siddharth Kaul | Director | A | — | — |
| 2024-05-28 | John Irving Bell | Director | A | — | — |
| 2024-05-28 | Peter John Ratcliffe | Director | A | — | — |
| 2024-05-28 | Roy Steven Herbst | Director | A | — | — |
| 2024-05-28 | Kristine Peterson | Director | A | — | — |
| 2024-04-03 | Tina Amber St Leger | CHIEF HR OFFICER | MIXED | — | — |
| 2024-03-01 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2024-02-28 | David M Berman | HEAD OF R&D | MIXED | — | — |
| 2024-02-21 | David M Berman | HEAD OF R&D | A | — | — |
| 2024-02-21 | Tina Amber St Leger | CHIEF HR OFFICER | A | — | — |
| 2024-02-21 | Bahija Jallal | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2024-02-21 | JOHN GOLL | SVP, FINANCE & CAO | A | — | — |
| 2024-02-21 | Brian Di Donato | CHIEF FINANCIAL OFFICER | A | — | — |
| 2024-01-05 | Tina Amber St Leger | Chief HR Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,144,060 | — |
| — | CHIEF EXECUTIVE OFFICER | 23,817 | — |
| — | HEAD OF R&D | 5,859 | — |
| — | CHIEF HR OFFICER | 2,119 | — |
| — | SVP, FINANCE & CAO | 653 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IMCR quote page; the site-wide leaderboard is on the insider transactions hub.